corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 5 of 206 pages ‹ First  < 3 4 5 6 7 >  Last ›

HSL19430
Preemie Birth Preventive Spikes From $10 To $1,500
npr 2011 Mar 9
http://yourlife.usatoday.com/parenting-family/pregnancy/story/2011/03/Preemie-birth-preventive-spikes-from-10-to-1500/44698212/1

HSL19345
Silverman E
Those Non-Branded DTC Ads Seem To Be Working
Pharmalot 2011 Mar 8
http://www.pharmalot.com/2011/03/those-non-branded-dtc-ads-seem-to-be-working/

HSL19349
Iafolla C
Strategy Setting: A Cautionary Tale
MediaPost Marketing: Health Blogs 2011 Mar 8
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=146248

HSL19350
Iskowitz M
Supremes won't revisit Bayer pay-for-delay case; FTC vows to press on
Medical Marketing & Media 2011 Mar 8
http://www.mmm-online.com/supremes-wont-revisit-bayer-pay-for-delay-case-ftc-vows-to-press-on/article/197914/

HSL19356
Feeley J, Henderson G
J&J Misled South Carolina Officials About Drug, Jury Told
Bloomberg News 2011 Mar 8
http://www.bloomberg.com/news/2011-03-08/j-j-misled-south-carolina-officials-about-risperdal-jury-told.html

HSL19355
Jack A
A sugared pill
The Finanical Times 2011 Mar 8
http://www.ft.com/cms/s/0/ae7099a0-49bc-11e0-acf0-00144feab49a.html#axzz1Gwb5fZso

HSL19348
Silverman E
Supreme Court Rejects Challenge To Pay-To-Delay
Pharmalot 2011 Mar 7
http://www.pharmalot.com/2011/03/supreme-court-rejects-challenge-to-pay-to-delay/

HSL19354
Beckford M
Quarter of doctors failed to report incompetent colleague
The Telegraph 2011 Mar 7
http://www.telegraph.co.uk/health/healthnews/8366746/Quarter-of-doctors-failed-to-report-incompetent-colleague.html

HSL19319
Harvey K
Ken Harvey: The risks from vague medicine labels
MJA InSight 2011 Mar 7;
http://www.mjainsight.com.au/view?post=Ken+Harvey%3A+The+risks+from +vague+medicine+labels&post_id=3572

HSL19317
Thomaselli R
Looking for Guidance, Pharma Left Waiting
Advertising Age 2011 Mar 7
http://adage.com/article/news/drug-makers-wait-fda-ruling-social-media-dtc-ads/149214/

HSL19323
Harris G
Talk Doesn’t Pay, So Psychiatry Turns Instead to Drug Therapy
The New York Times 2011 Mar 6
http://www.nytimes.com/2011/03/06/health/policy/06doctors.html?_r=1

HSL19315
Wilson D
Drug Firms Face Billions in Losses in ’11 as Patents End
The New York Times 2011 Mar 6
http://www.nytimes.com/2011/03/07/business/07drug.html?_r=1

HSL19320
Goldacre B
Drug trial secrecy leaves us dependent on blind faith
The Guardian 2011 Mar 5
http://www.guardian.co.uk/commentisfree/2011/mar/05/bad-science-drug-trial-secrecy

HSL19352
Experts call for clearer medicine labelling
NursingTimes.net 2011 Mar 4
http://www.nursingtimes.net/whats-new-in-nursing/news-topics/public-health/experts-call-for-clearer-medicine-labelling/5026755.article

HSL19316
Silverman E
Lawsuit Over J&J Risperdal Marketing Can Proceed
Pharmalot 2011 Mar 4
http://www.pharmalot.com/2011/03/lawsuit-over-jj-risperdal-marketing-can-proceed/

HSL19314
How Are Physicians Responding to the FDA's Bad Ad Program?
Pharma Live 2011 Mar 4
http://pharmalive.com/news/index.cfm?articleID=766168

HSL19451
Silverman E
Most Docs Are Unaware Of FDA ‘Bad Ad’ Program
Pharmalot 2011 Mar 4
http://www.pharmalot.com/2011/03/most-docs-are-unaware-of-fda-bad-ad-program/

HSL19716
Gever J
New Twist in Colloids-Crystalloids Tussle
MedPage Today 2011 Mar 4
http://www.medpagetoday.com/Anesthesiology/Anesthesiology/25198

HSL19301
Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC
The ClinicalTrials.gov Results Database — Update and Key Issues
NEJM 2011 Mar 3;364:852-860
http://www.nejm.org/doi/full/10.1056/NEJMsa1012065#t=articleBackground

HSL19308
Silverman E
Astellas Loses Lawsuit Against French Med Journal
Pharmalot 2011 Mar 3
http://www.pharmalot.com/2011/03/astellas-loses-lawsuit-against-french-med-journal/

HSL19309
Silverman E
Amgen Execs Take The 5th Over Alleged Kickbacks
Pharmalot 2011 Mar 3
http://www.pharmalot.com/2011/03/former-amgen-execs-take-the-fifth-before-trial/

HSL19310
Forest Pharmaceuticals Sentenced to Pay $164 Million for Criminal Violations
Fierce Pharma 2011 Mar 3
http://www.fiercepharma.com/press_releases/forest-pharmaceuticals-sentenced-pay-164-million-criminal-violations

HSL19311
Taylor L
Thousands protest India/EU FTA's generic drug provisions
Pharma Times 2011 Mar 3
http://www.pharmatimes.com/Article/11-03-03/Thousands_protest_India_EU_FTA_s_generic_drug_provisions.aspx

HSL19465
Noah T
The Make-Believe Billion
Slate 2011 Mar 3
http://www.slate.com/articles/business/the_customer/2011/03/the_makebelieve_billion.html

HSL19312
Masoni M, Guelfi MR, Gensini GF
Online healthcare advertising needs regulation
BMJ 2011 Mar 3;342:
http://www.bmj.com/content/342/bmj.c5778.extract

HSL19313
Hall D, Jones S, Iverson D
Disease awareness advertising – women’s intentions following exposure
Australian Family Physician 2011 Mar 3;40:(3):143-147
http://www.racgp.org.au/afp/201103/41511

HSL19304
Silverman E
Boo! The NIH Grapples With Ghostwriting
Pharmalot 2011 Mar 2

HSL19305
Astellas' lawsuit against Prescrire: French court rules that Prescrire did not
Prescrire Int. 2011 Mar 2
http://english.prescrire.org/en/81/168/46799/0/NewsDetails.aspx

HSL19306
Le laboratoire Astellas Pharma perd son procès contre la revue Prescrire
Dépêche AFP 2011 Mar 2
http://www.france24.com/fr/20110302-le-laboratoire-astellas-pharma-perd-son-proces-contre-revue-prescrire?quicktabs_1=0

HSL19302
Arnold M
Much ado about mommy bloggers, mobile apps and paid posts
Medical Marketing & Media 2011 Mar 2
http://www.mmm-online.com/much-ado-about-mommy-bloggers-mobile-apps-and-paid-posts/article/197410/

HSL19299
Aston G
Navigating The Future Of DTC Advertising
MediaPost Marketing: Health Blogs 2011 Mar 2
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=145699

HSL19296
Iskowitz M
Off-label marketing offenses cost Elan $203 million
Medical Marketing & Media 2011 Mar 1
http://www.mmm-online.com/off-label-marketing-offenses-cost-elan-203-million/article/197340/

HSL19298
Roehr B
Medical journals with advertising are more likely than subscription journals to recommend drugs
BMJ 2011 Mar 1;342:
http://www.bmj.com/content/342/bmj.d1335.extract

HSL19297
Pogachar M
Questions Linger on Social Media Regulations for Pharma
iHealthBeat 2011 Mar 1
http://www.ihealthbeat.org/features/2011/questions-linger-on-social-media-regulations-for-pharma.aspx#ixzz1FProUyyp

HSL19442
Sales Through Retail Pharmacies (Twelve months to January 2011)
ims 2011 Mar
http://view.respond.imshealth.com/?j=fe5a1579716304757611&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe29167370610479771c79&r=0

HSL19288
Silverman E
Drugmakers Will Expand Which Sales Teams?
Pharmalot 2011 Feb 28
http://www.pharmalot.com/2011/02/drugmakers-will-expand-which-sales-teams/

HSL19292
Widely read free medical journals hype drugs: study
Reuters 2011 Feb 28
http://wtaq.com/news/articles/2011/feb/28/widely-read-free-medical-journals-hype-drugs-study/

HSL19291
Becker A, Dörter F, Eckhardt K, Viniol A, Baum E, Kochen MM, Lexchin J, Wegscheider K, Donner-Banzho N
The association between a journal's source of revenue and the drug recommendations made in the articles it publishes
CMAJ 2011 Feb 28;
http://www.cmaj.ca/cgi/content/abstract/cmaj.100951v1

HSL19322
Mackintosh M, Chaudhuri S, Mujinja PGM
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Globalization and Health 2011 Feb 28;7:(1):4
http://www.globalizationandhealth.com/content/7/1/4

HSL19289
Silverman E
Abbott Pays Mommy Blogs To Review Similac App
Pharmalot 2011 Feb 28
http://www.pharmalot.com/2011/02/abbott-pays-mommy-blogs-to-review-similac-app/

HSL19290
Taylor L
EMA warned of potential 'conflicts of interest' involving former exec director
Pharma Times 2011 Feb 28
http://www.pharmatimes.com/Article/11-02-28/EMA_warned_of_potential_“conflicts_of_interest”_involving_former_exec_director.aspx

HSL19432
Kesselheim AS.
Covert pharmaceutical promotion in free medical journals.
CMAJ 2011 Feb 28;183:(5):534-5
http://www.cmaj.ca/cgi/content/full/183/5/534

HSL19351
Krumholz HM
Examining an Ad for a Platelet-Inhibition Test
CardioExchange 2011 Feb 27
http://www.cardioexchange.org/examining-an-ad-for-a-platelet-inhibition-test/

HSL19284
Thacker T
All eyes on banned drugs
Indian Express 2011 Feb 26
http://www.indianexpress.com/news/all-eyes-on-banned-drugs/755175/0

HSL19294
Edwards J
J&J May Be Liable for Antipsychotic Kickback Scheme Despite “Legal” Contract
BNet 2011 Feb 25
http://www.bnet.com/blog/drug-business/j-j-may-be-liable-for-antipsychotic-kickback-scheme-despite-8220legal-8221-contract/7531

HSL19328
Braillon A
Stimulating the interest for conflicting scientific debates
The American Journal of Medicine Blog 2011 Feb 25
http://amjmed.blogspot.com/2011/02/stimulating-interest-for-conflicting.html

HSL19282
European drug regulator challenged over revolving door case involving former Director
ALTER-EU, HAI, ISDB 2011 Feb 25

HSL19295
Edwards J
Payola at Novartis: Theraflu App Got Rave Reviews From 'Sponsored' Bloggers
BNet 2011 Feb 25
http://www.bnet.com/blog/drug-business/payola-at-novartis-theraflu-app-got-rave-reviews-from-8220sponsored-8221-bloggers/7511

HSL19325
Mission Médiator et pharmacovigilance - Dr Alain Braillon
Assemblee Nationale 2011 Feb 240
http://www.assemblee-nationale.tv/chaines.html?dossier=Commissions&commission=MED_PHAR

HSL19280
Joint Open Letter Calling Novartis to cease seemingly endless legal process in India
HAI Europe 2011 Feb 24
http://haieurope.org/wp-content/uploads/2011/02/22-Feb-2011-Open-Letter-to-Novartis.pdf

HSL19264
Liang BA, Mackey T
Direct-to-Consumer Advertising With Interactive Internet Media Global Regulation and Public Health Issues
JAMA 2011 Feb 23;305:(8):824-825
http://ehln.org/?p=14324

HSL19273
Rothman DJ, Chimonas S
Academic Medical Centers' Conflict of Interest Policies
JAMA 2011 Feb 23;305:(8):743-844
http://jama.ama-assn.org/content/304/20/2294.extract

HSL19265
Iskowitz M
Orphan patient communities grow online
Medical Marketing & Media 2011 Feb 23
www.mmm-online.com/orphan-patient-communities-grow-online/article/196829

HSL19293
Edwards J
Abbott Pays Bloggers For Positive Reviews of Its Similac App
BNet 2011 Feb 23
http://www.bnet.com/blog/drug-business/abbott-pays-bloggers-for-positive-reviews-of-its-similac-app/7496

HSL19211
Weisman N
The Importance Of Branding In Clinical Trials
MediaPost Marketing: Health Blogs 2011 Feb 23
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=145404

HSL19271
Taylor L
'Dramatic changes' set for Australian pharma
Pharma Times 2011 Feb 23
http://www.pharmatimes.com/Article/11-02-23/Dramatic_changes_set_for_Australian_pharma.aspx

HSL19270
Silverman E
Americans & Canadians Get Different Drug Info Online
Pharmalot 2011 Feb 23
http://www.pharmalot.com/2011/02/americans-canadians-get-different-drug-info-online/

HSL19269
Law MR, Mintzes B, Morgan SG
The Sources and Popularity of Online Drug Information: An Analysis of Top Search Engine Results and Web Page Views
The Annals of Pharmacotheraphy 2011 Feb 22;
http://www.theannals.com/cgi/content/abstract/aph.1P572v1

HSL19368
Steen RG.
Misinformation in the medical literature: What role do error and fraud play?
J Med Ethics 2011 Feb 22;
http://jme.bmj.com/content/early/2011/02/22/jme.2010.041830.long

HSL19204
Deceitful pharmacies?
Pharmacy Daily 2011 Feb 22
www.pharmacydaily.com.au

HSL19207
Silverman E
Pfizer Reaches Deal To Resolve All Trovan Litigation
Pharmalot 2011 Feb 22
http://www.pharmalot.com/2011/02/pfizer-reaches-deal-to-resolve-all-trovan-litigation/

HSL19208
Silverman E
Which Oncology Meds Do Sales Reps Push The Most?
Pharmalot 2011 Feb 22
http://www.pharmalot.com/2011/02/which-sales-reps-rank-highest-with-oncologists/

HSL19209
Silverman E
Bills Would End DTC Tax Break & Allow Importation
Pharmalot 2011 Feb 22
http://www.pharmalot.com/2011/02/bills-would-end-dtc-tax-breaks-allow-importation/

HSL19190
Grant RP
Never knowingly understated
The Scientist: Naturally Selected 2011 Feb 21
http://web.archive.org/web/20110222040258/http://blog.the-scientist.com/2011/02/21/never-knowingly-understated/

HSL19213
J&J to pay $73 million in legal costs over Risperdal
APP.com 2011 Feb 18
http://www.app.com/article/20110217/NJBIZ/110217030/J-J-to-pay-73-million-in-legal-costs-over-Risperdal

HSL19193
Grogan K
GSK sets aside £2.2 billion for Avandia and marketing probes
Pharma Times 2011 Feb 18
http://www.pharmatimes.com/Article/11-01-18/GSK_sets_aside_%C2% A32_2_billion_for_Avandia_and_marketing_probes.aspx

HSL19202
Padma TV
Foreign takeovers threaten India's generic drug supply
SciDev Net 2011 Feb 18
http://www.scidev.net/en/news/foreign-takeovers-threaten-india-s-generic-drug-supply.html

HSL19205
Silverman E
Senate Bill Would Restrict Authorized Generics
Pharmalot 2011 Feb 18
http://www.pharmalot.com/2011/02/senate-bill-would-restrict-authorized-generics/

HSL19214
McConaghie A
Value-based pricing will not harm industry, says NICE chief
InPharm 2011 Feb 18
http://www.inpharm.com/news/148696/value-based-pricing-will-not-harm-industry-says-nice-chief

HSL19131
Feeley J
AstraZeneca Said to Settle More Seroquel Lawsuits
Bloomberg Businessweek 2011 Feb 17
http://www.businessweek.com/news/2011-02-17/astrazeneca-said-to-settle-more-seroquel-lawsuits.html

HSL19212
Hobson K
Nurse Practitioners Get Free Meals From Pharma, Too
The Wall Street Journal Blog 2011 Feb 17
http://blogs.wsj.com/health/2011/02/17/nurse-practitioners-get-free-meals-from-pharma-too/

HSL19281
Nestle Press Release
Nestle 2011 Feb 17
http://www.nestle.com/Media/PressReleases/Pages/AllPressRelease.aspx?Name=Full-Year-Results-2010&PressReleaseYear=2010&Title=Full+Year+Results+2010&PageName=2010.aspx

HSL19119
Grogan K
USA probes Novo Nordisk's marketing practices
Pharma Times 2011 Feb 16
http://www.pharmatimes.com/Article/11-02-16/USA_probes_Novo_Nordisk_s_marketing_practices.aspx

HSL19122
Arnold M
Apps on fire, but pharmas losing the mobile health arms race, says report
Medical Marketing & Media 2011 Feb 16
http://www.mmm-online.com/apps-on-fire-but-pharmas-losing-the-mobile-health-arms-race-says-report/article/196489/

HSL19123
Voelker R
Study: Few Advocacy Groups Disclose Grants From Drug Companies
JAMA 2011 Feb 16;305:(7):662
http://jama.ama-assn.org/content/305/7/662.extract

HSL19130
Comer B
Sales reps say medical knowledge, business acumen are keys to access
Medical Marketing & Media 2011 Feb 16
http://www.mmm-online.com/sales-reps-say-medical-knowledge-business-acumen-are-keys-to-access/article/196486/

HSL19303
Arnold M
Boehringer Ingelheim contest seeks COPD songs
Medical Marketing & Media 2011 Feb 15
http://www.mmm-online.com/boehringer-ingelheim-contest-seeks-copd-songs/article/197386/

HSL19405
Graben R, Sullivan M
Special Teams
Medical Marketing & Media 2011 Feb 15
http://www.mmm-online.com/special-teams/article/196817/

HSL19109
Pharma Corruption: 'BayerGate' still not investigated
Coalition against Bayer Dangers (Germany) 2011 Feb 15

HSL19120
Nadler Pushes to End Tax Breaks for Pharmaceutical Companies
PharmaLive 2011 Feb 15
http://pharmalive.com/news/index.cfm?articleID=762002

HSL19124
Grogan K
PhRMA blasts Obama over pay-for-delay ban plan
Pharma Times 2011 Feb 15
http://www.pharmatimes.com/Article/11-02-15/PhRMA_blasts_Obama_over_pay-for-delay_ban_plan.aspx

HSL19183
Lexchin J
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Tria ls of Medications
Sci Eng Ethics 2011 Feb 15;

HSL19110
Check Out the Documentary Orgasm, Inc
The Huffington Post 2011 Feb 14
http://www.huffingtonpost.com/joyce-mcfadden/check-out-the-documentary_b_822066.html

HSL19111
Thought Leader Select Announces Media Partnership with Marketing4Health
Thought Select Leader 2011 Feb 14
http://www.thoughtleaderselect.com/2011/02/14/thought-leader-select-announces-media-partnership-with-marketing4health/

HSL19113
Silverman E
FDA Warns Novartis Over Flu Vaccine Promotion
Pharmalot 2011 Feb 14
http://www.pharmalot.com/2011/02/fda-warns-novartis-over-flu-vaccine-promotion/

HSL19114
Silverman E
Drugmakers & PBMs Square Off Over E-Prescribing
Pharmalot 2011 Feb 14
http://www.pharmalot.com/2011/02/drugmakers-pbms-square-off-over-e-prescribing/

HSL19121
Comer B
Docs say pharma is dropping the ball with Hispanics: survey
Medical Marketing & Media 2011 Feb 14
http://www.mmm-online.com/docs-say-pharma-is-dropping-the-ball-with-hispanics-survey/article/196363/

HSL19135
Evans R, Lewis P
Revealed: how energy firms spy on environmental activists
The Guardian 2011 Feb 14
http://www.guardian.co.uk/environment/2011/feb/14/energy-firms-activists-intelligence-gathering

HSL19326
Braillon Alain, Dubois G
Alcohol Control Policy: Evidence-Based Medicine Versus Evidence-Based Marketing
Addiction 2011 Feb 14;106:852–853
http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2010.03319.x/pdf

HSL19105
Homeopathy: what’s in it?
Pharmacy Daily 2011 Feb 11
http://tdlists.traveldaily.com.au/new/link.php?M=39921&N=8974&L=1297&F=H

HSL19112
Fluvirin (Influenza Virus Vaccine) - Untitled Letter
PharmaLive 2011 Feb 11
http://pharmalive.com/news/index.cfm?articleID=761367

HSL19098
Arnold M
To dial down DTC, let companies collaborate on ads, says ex-Merck exec
Medical Marketing & Media 2011 Feb 10
http://www.mmm-online.com/to-dial-down-dtc-let-companies-collaborate-on-ads-says-ex-merck-exec/article/196107/

HSL19099
Spatz ID
Better Drug Ads, Fewer Side Effects
The New York Times 2011 Feb 10
http://www.nytimes.com/2011/02/10/opinion/10spatz.html?_r=1

HSL19100
Silverman E
Should Congress Change The Rules On DTC Ads?
Pharmalot 2011 Feb 10
http://www.pharmalot.com/2011/02/should-congress-changes-the-rules-on-dtc-ads/

HSL19101
Silverman E
Who Discovers Innovative Meds? The Public Sector
Pharmalot 2011 Feb 10
http://www.pharmalot.com/2011/02/who-discovers-innovative-meds-the-public-sector/

HSL19103
Silverman E
Former Pfizer Doc Renews His Trovan Allegations
Pharmalot 2011 Feb 10
http://www.pharmalot.com/2011/02/former-pfizer-doc-renews-his-trovan-allegations/

HSL19115
A Quiet Campaign to Raise Prescription Drug Costs, Undermine Safety
PharmaLive 2011 Feb 10
http://pharmalive.com/news/index.cfm?articleid=760949

HSL19117
Hensley S
Is It Time To Dial Back The Drug Ad Arms Race?
Shots: NPR Health Blog 2011 Feb 10
http://www.npr.org/blogs/health/2011/02/11/133648578/is-it-time-to-dial-back-the-drug-ad-arms-race

HSL19203
Bloss CS, Schork NJ, Topol EJ,
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
NEJM 2011 Feb 10;
http://www.nejm.org/doi/full/10.1056/NEJMoa1011893

HSL19070
Iafolla C
Content Curation: A Path to Pharma Social Media Success?
MediaPost Marketing: Health Blogs 2011 Feb 9
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=144452

Page 5 of 206 pages ‹ First  < 3 4 5 6 7 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.